KHAN Technology Transfer Fund is in an early-stage life sciences venture fund. Our mission is to create value through cooperative drug development partnerships with academic innovators in Europe and special focus on Germany. We focus on first-in-class therapies for attractive markets with a high unmet medical need for the sake of the patients. The fund is managed by Khanu, an experienced team of professionals with proven track records in early-stage drug development, academic spin-offs as well as pharma licensing and partnering.
Company Details
- Founded
- 2019
- Address
- Otto-Hahn-Straße 15, Dortmund,north Rhine - Westfalia 44227,germany
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.khanu.de
- Keywords
- Pre-Seed, Seed, Series A investments in drug discovery projects and academic spin-off companies.
- HQ
- Dortmund, North Rhine - Westfalia
Khan Technology Transfer Fund Questions
Khan Technology Transfer Fund's website is http://www.khanu.de
Khan Technology Transfer Fund's LinkedIn profile is https://de.linkedin.com/company/khan-technology-transfer-fund
Khan Technology Transfer Fund's industry is
Venture Capital and Private Equity Principals
Khan Technology Transfer Fund's top competitors are
Lead Discovery Center Gmbh,
Cumulus Oncology,
University Of Michigan Global Scholars Program,
Sekka - Money Transfer & Foreign Exchange,
Khanu Management Gmbh,
"stak Money Transfer" Cjsc,
Cleracs Consulting,
Family Office Alliance,
Hi, Na?,
Wings4innovation Gmbh.
Khan Technology Transfer Fund's categories are Venture Capital and Private Equity Principals
Khan Technology Transfer Fund's founding year is 2019
